Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/07/1996CA2168827A1 Glycoproteins, process for preparation thereof, and pharmaceutical composition
08/06/1996US5543562 Non-hygroscopic monoammonium salts of phosphonic acids or phosphinic acids
08/06/1996US5543508 Having two oligoribonucleotide regions with predetermined sequences capable of hybridizing with target rna sequences
08/06/1996US5543505 Treatment of gastrointestinal disorders
08/06/1996US5543503 Antiinflammatory agents
08/06/1996US5543499 Genetic engineering
08/06/1996US5543498 Peptides to overcome inhibition of nerve growth
08/06/1996US5543496 Cyclic bradykinin antagonist peptides
08/06/1996US5543430 Method and formulation of stimulating nitric oxide synthesis
08/06/1996US5543399 Cystic fibrosis transmembrane conductance regulator (CFTR) protein
08/06/1996US5543397 Glutamine source in culture medium
08/06/1996US5543396 Dipeptides as enzyme inhibitors of serine proteases; antiinflammatory and -tumor agents; anticoagulants; aids
08/06/1996US5543394 Bone morphogenetic protein 5(BMP-5) compositions
08/06/1996US5543393 Blend with a nonionic surfactant
08/06/1996US5543392 Containing epidermal growth factor
08/06/1996US5543328 Adenoviruses having modified fiber proteins
08/06/1996US5543320 Genetic engineering
08/06/1996US5543312 Gene expression, cloning a dna sequence
08/06/1996US5543149 Treatment for insect bites
08/06/1996US5543144 Treating hypersensitivities with anti-IGE monoclonal antibodies which bind to IGE-expressing B cells but not basophils
08/06/1996US5543143 Method for activating macrophages/monocytes
08/06/1996US5543141 For stimulating the production of hematopoietic cells
08/06/1996US5543140 Method and use of IL-1α
08/06/1996US5543139 5.5 kD TNF degradation product
08/06/1996US5543138 Methods of diagnosing and treating preeclampsia
08/06/1996CA2026783C Use of il-7 in providing medications for stimulation of platelet production
08/04/1996CA2146581A1 Synergistic effect of insulin-like growth factor-i and erythropoietin
08/01/1996WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
08/01/1996WO1996023071A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
08/01/1996WO1996023069A1 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023067A1 Human interleukin-1 receptor accessory protein
08/01/1996WO1996023066A2 Prostaglandin receptor, dp
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
08/01/1996WO1996023060A1 Method for isolating dendritic cells
08/01/1996WO1996023059A1 Lineage-directed induction of human mesenchymal stem cell differentiation
08/01/1996WO1996023039A1 Plasma and polymer containing surgical hemostatic adhesives
08/01/1996WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness
08/01/1996WO1996023000A1 Ligands for eph-like receptors
08/01/1996WO1996022999A1 Peptides which inhibit viruses
08/01/1996WO1996022998A1 Thiol derivatives with metallopeptidase inhibitory activity
08/01/1996WO1996022997A1 Compounds with growth hormone releasing properties
08/01/1996WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996WO1996022790A1 Composition to ameliorate osteolysis and metastasis
08/01/1996WO1996022788A1 LYMPHOTOXIN-α/β COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
08/01/1996WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof
08/01/1996WO1996022786A1 Sustained-release preparation and use
08/01/1996WO1996022785A1 Methods for the treatment of acid aspiration-induced acute lung injury
08/01/1996WO1996022784A1 Novel antifungal cyclohexapeptides
08/01/1996WO1996022783A1 Method of enhancing nutrient uptake
08/01/1996WO1996022782A1 Novel highly potent agonists of growth hormone releasing hormone
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996WO1996022773A1 Methods and compositions for lipidization of hydrophilic molecules
08/01/1996WO1996022763A1 Liposome for destroying hiv and cells infected by said virus
08/01/1996WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/01/1996WO1996022689A1 Multiple component rna catalysts and uses thereof
08/01/1996WO1996016170A3 Proteins involved in the regulation of cell-cell adhesion and uses thereof
08/01/1996WO1996013593A3 Soluble single chain t cell receptors
08/01/1996WO1996013592A3 Protein kinase npk-110
08/01/1996WO1996013586A3 Histiocyte-secreted factor (hsf)
08/01/1996WO1996012811A3 Yeast telomerase components and methods using them
08/01/1996WO1996012736A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY
08/01/1996WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
08/01/1996DE19502436A1 New complementary peptide(s) for treating prion protein disease
08/01/1996CA2211842A1 Method of enhancing nutrient uptake
08/01/1996CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996CA2211468A1 Recombinant dna comprising dna coding for myosin heavy chain sm1 isoform protein inserted into vector dna, microorganism carrying the recombinant dna, and an agent for treatment of arteriosclerosis comprising the recombinant dna
08/01/1996CA2211443A1 Lymphotoxin-.alpha./.beta. complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents
08/01/1996CA2211442A1 Methods and compositions for lipidization of hydrophilic molecules
08/01/1996CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
08/01/1996CA2211138A1 Novel antifungal cyclohexapeptides
08/01/1996CA2211122A1 Novel highly potent agonists of growth hormone releasing hormone
08/01/1996CA2211115A1 Methods for the treatment of acid aspiration-induced acute lung injury
08/01/1996CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/01/1996CA2210724A1 Human interleukin-1 receptor accessory protein
08/01/1996CA2210644A1 Ligands for eph-like receptors
08/01/1996CA2210419A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/1996CA2210151A1 Thiol derivatives with metallopeptidase inhibitory activity
08/01/1996CA2155043A1 Anti-motoneuron-disease agent
07/1996
07/31/1996EP0723974A1 Derivatives of mercaptoalkanoyldipeptides, their preparation and pharmaceutical compositions containing them
07/31/1996EP0723782A1 Use of a preparation comprising a plasminogen activator to improve wound healing
07/31/1996EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP
07/31/1996EP0723663A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods
07/31/1996EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin
07/31/1996EP0723588A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
07/31/1996EP0723587A1 Deoxyribonucleic acids containing inactivated hormone responsive elements
07/31/1996EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof
07/31/1996EP0723556A1 Fas antagonists and uses thereof
07/31/1996EP0723555A1 Chimeric proteins which block complement activation
07/31/1996EP0723553A1 Compounds useful in anti-allergy treatment
07/31/1996EP0723552A1 Oligopeptides derived from c-reactive protein fragments
07/31/1996EP0723545A1 Quinolizinone type compounds
07/31/1996EP0723460A1 Gene therapy of the nervous system
07/31/1996EP0723458A1 Immune modulation with class ii alpha-chain fragments
07/31/1996EP0723457A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
07/31/1996EP0723456A1 Methods for stimulating erythropoiesis using thrombopoietin
07/31/1996EP0723455A1 Methods of inhibiting phagocytosis
07/31/1996EP0723454A1 Novel tripeptides useful in immune and cns therapy
07/31/1996EP0723453A1 Method of treating reproductive disorders
07/31/1996EP0723451A1 Use of lithium compounds for treating high blood pressure
1 ... 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 ... 3163